Evercore ISI reiterates Karman stock rating after filing delay By Investing.com

Karman Holdings (KRMN) is trading at $86.15 after a 139% one-year gain; Evercore ISI reiterated an Outperform with a $125 target following a procedural 10-K filing delay that the company expects to cure within a standard 15‑day extension. Q4 results beat on revenue with 31% organic growth and maintained a 31% EBITDA margin, and management raised fiscal 2026 outlook despite some contract timing delays and a higher backlog from missile, drone and space programs. Multiple firms (Piper Sandler $127 PT, KeyBanc, William Blair, Truist) reiterated bullish ratings while BWS Financial remains a Sell citing cash‑flow and rising contract assets, leaving a generally positive but mixed analyst backdrop.

Analysis

Karman sits at the intersection of a lumpy, program-driven defense revenue stream and an aggressive M&A/granular production ramp. That combination tends to inflate backlog figures while pressuring near-term working capital and integration-related SG&A; expect receivable/contract-asset conversion and ERP/ops harmonization to drive quarter-to-quarter margin volatility even if top-line growth remains intact.

Second-order winners are mid-tier suppliers of propulsion, guidance electronics and composite airframes: limited specialist capacity creates pricing power and delivery bottlenecks that can accelerate supplier profit cycles for 6–24 months. Conversely, legacy prime contractors could face short-term production friction as smaller, faster vendors capture niche awards, shifting subcontract mix away from large OEMs and into more fragmented specialist suppliers.

Key risks are audit/financial-reporting adjustments, working-capital-driven cash burn and timing of government awards tied to appropriations cycles — any adverse development here can compress equity multiples quickly. Near-term catalysts (upcoming reporting milestones, backlog conversion over the next 2–4 quarters, and FY funding decisions) create binary outcomes: smooth execution should re-rate shares; slips increase dilution and credit risk. The consensus is bullish on growth but underweights cash conversion and integration execution risk; that divergence is our entry/hedge lever.

Key Decisions for Investors

• Long-KRMN equity with tactical hedge: Buy KRMN on pullbacks below $95, target $135 within 6–12 months (≈+40% upside vs a tactical stop at -20%). Hedge with 1:1 6-month puts (strike ~80) to cap downside — asymmetric R/R ~2:1 if execution holds.
• Call-focused asymmetric bet: Buy 9–12 month KRMN calls (delta ~30–40) rather than outright stock to limit downside. Breakeven requires catalytic proof-points (clean audited filing + two quarters of cash conversion improvement); if those occur, expect >2x on premium paid.
• Pair trade to isolate company execution risk: Long KRMN / short 0.5x ITA (Ishares U.S. Aerospace & Defense ETF) sized to neutralize sector moves for 6 months. This isolates idiosyncratic upside from backlog conversion while hedging macro/defense cyclical risk.
• Risk-managed short catalyst: If contract assets (unbilled receivables) grow another 20–30% QoQ or cash conversion deteriorates materially, consider a short or buy-put spread in KRMN sized for a 6–12 month horizon — target 30–50% downside on realization or dilution events.